Gordius (Gabapentin)

Gordius (gabapentin) is indicated for several neurological and pain‑related conditions, as determined by a healthcare professional, and is commonly prescribed as part of a broader treatment plan.

• Epilepsy: adjunctive therapy for partial seizures.
• Postherpetic neuralgia: relief of nerve pain after shingles.
• Diabetic or other peripheral neuropathic pain.
• Restless legs syndrome: reduction of uncomfortable sensations.
• Off‑label use for certain anxiety disorders when clinically justified.

Side‑effect profiles for Gordius reflect the pharmacology of gabapentin and vary among individuals.

Common

• Dizziness or light‑headed feeling.
• Fatigue or drowsiness.
• Peripheral edema (swelling of hands or feet).
• Visual disturbances such as double vision.
• Nausea or mild gastrointestinal upset.

Serious

• Severe allergic reactions (rash, swelling, difficulty breathing).
• Mood changes including depression or suicidal thoughts.
• Unusual muscle weakness or coordination problems.
• Rapid heart rate or chest pain.
• Signs of liver dysfunction (jaundice, dark urine).

Before starting Gordius, clinicians should evaluate patient history and monitor for specific safety concerns.

• Assess renal function; dose adjustment may be required in impaired kidneys.
• Review history of mood disorders or suicidal ideation.
• Use cautiously in elderly patients due to increased risk of falls.
• Avoid abrupt discontinuation to prevent withdrawal symptoms.
• Counsel patients on potential drowsiness and advise against operating machinery.
• Consider pregnancy status; benefits must outweigh potential risks.
• Monitor for signs of peripheral edema or weight gain.

Gabapentin can interact with other medicines, influencing its effectiveness or safety profile.

Avoid

• Antacids containing aluminum or magnesium taken within two hours of the dose (may reduce absorption).
• Central nervous system depressants such as opioids, benzodiazepines, or alcohol (enhanced sedation).

Use with caution

• Certain antiepileptic drugs (e.g., carbamazepine, phenobarbital) that may lower gabapentin levels.
• Diuretics that affect renal clearance.
• Medications that prolong QT interval (monitor cardiac status).
• Drugs that cause significant weight gain or edema.